← Map · Health Care Equipment · S&P MidCap 400
BRKR BRUKER $9.2B
No. A stake and two demo labs, not a Bruker customer.
6 of 15
Reach, Weight, and Proof.
What they are doing
Bruker took a minority stake in Atinary and said the Atinary labs in Basel and Boston run closed-loop research with agentic AI, Chemspeed robots, and Bruker benchtop NMR. Atinary intends to fold Bruker instruments into those workflows. Bruker has not named a customer using this as a Bruker product.
Why the score
- Reach 1 not 2: one collaboration. Not a second function inside Bruker.
- Weight 2 not 3: the live loop sits in the partner demo lab. Bruker still sells instruments.
- Proof 3 not 4: the labs are named and described as running. No customer result.
What would move it next quarter: A named customer on the self-driving lab, reported by Bruker. Another instrument booking will not move this.
Open these first
Evidence
Bruker made a minority investment in Atinary. Atinary intends to integrate Chemspeed automation, Bruker instruments, and SciY software into its agentic AI workflows. The Atinary labs in Basel and Boston demonstrate closed-loop research powered by agentic AI, including Bruker benchtop NMR.